Giulio Superti-Furga and Kilian Huber at CeMM Win GlaxoSmithKline’s European Discovery Fast Track Challenge to Investigate a New Anti-Cancer Drug Targeting MTH1
Giulio Superti-Furga, Scientific Director and Kilian Huber, Senior Postdoctoral Fellow at CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, have been selected as winners of GlaxoSmithKline plc’s (GSK) 2014 European Discovery Fast Track Challenge, which is designed to accelerate the translation of academic research into novel therapies. CeMM will partner with scientists in GSK’s Discovery Partnerships with Academia…
CeMM Scientific Director Giulio Superti-Furga elected member of the Academia Europaea
CeMM Scientific Director Giulio Superti-Furga was recently elected member of the Academia Europaea – the Academy of Europe. The election followed a recommendation of the Academic Sections and a peer review by the Nominations Committee of the academy. The Academia Europaea is a registered not-for-profit charity founded in 1988 as an international, nongovernmental association of eminent, individual scientists and scholars from across the continent…
Vienna-Munich collaboration identifies JAGN1 as a novel key regulator of neutrophil survival and function
Congenital immunodeficiencies comprise a group of disorders characterized by an abnormal immune system. The body’s ability to fight infections is impaired and infections can have life-threatening consequences for those affected. Analysis of patients with a disease characterized by an inherited lack of neutrophil granulocytes termed severe congenital neutropenia (SCN) may shed light on the delicate balance of factors controlling differentiation,…
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
Genetic requirement for drug action is important to study as it may reveal mechanism of drug resistance, particularly in cancer, as well as generate ideas for better, safer and more personalized drugs. The laboratory of CeMM Director Giulio Superti-Furga used a genetic screen with human haploid cells, based on the work of Thijn Brummelkamp and his team (NKI and CeMM Adjunct PI), to identify the genes affecting the action of a poorly understood…
Presentation of CeMM Research Report
On Friday, July 25, the new research report was presented to a selected audience on the CeMM terrace. The concept of the current report is a wonderful example of our dialogue with society. Our befriended artist, Dorothee Golz, approached us with the idea of having a geneticist collaborate with her to unravel the traits in a particular branch of the body of her oeuvre that allows for a proper “genealogy”. What ensued is presented in this report…
Principal Investigator Position(s) at CeMM
We are looking for MD and/or PhD scientists either at their first independent appointment or already at the consolidation stage to apply their expertise close to a clinical setting in a stimulating research environment.Are you full of ideas and impatient for action to translate the opportunities of the genomic age into better therapeutics and diagnostics? Do you have a truly collaborative mindset and enjoy teamwork across disciplines? Do you…
Erwin Schrödinger Prize for Denise Barlow
With great pleasure we announce that Denise Barlow, Principal Investigator at CeMM and Honorary Professor of Genetics at the University of Vienna, has received the Erwin Schrödinger Prize 2014 for lifetime achievements. The Erwin Schrödinger Prize is an annual award presented by the Austrian Academy of Sciences for lifetime achievement in the fields of mathematics and natural sciences. This prize is the most prestigious award of the Austrian…
EMBanniversary AUSTRIA Conference – Celebrating 50 years of EMBO, 40 years of EMBL and the Success of Molecular Biology in Austria
July 06 - 08, 2014 More than 40 speakers, session chairs and special guests together with guests representing the Austrian molecular biology and life sciences community celebrated the 50th and 40th anniversaries of the European Molecular Biology Organization (EMBO) and the European Molecular Biology Laboratory (EMBL) and their impact in Austria, with a dedicated event. EMBanniversary AUSTRIA, a unique fusion of a scientific conference, alumni…
Recognition by Austrian Academy of Sciences for two Principal Investigators of CeMM
The Austrian Academy of Sciences (ÖAW) has announced their newly elected members. Among them are two Principal Investigators of CeMM. We congratulate Sylvia Knapp for being elected as Corresponding Member and Sebastian Nijman for having been named as member of the Chapter of Young Scientists (“Junge Kurie”). Giulio Superti-Furga, Scientific Director of CeMM: “We are very proud of the scientific excellence of the two group leaders. This…
8th CeMM Karl Landsteiner Lecture by David M. Sabatini
The 8th CeMM Karl Landsteiner Lecture at the beautifully frescoed Festive Hall of the Austrian Academy of Sciences was delivered by Prof. David M. Sabatini of the Whitehead Institute for Biomedical Research of the Massachusetts Institute of Technology (MIT). More than 350 scientists and interested lay people from all walks of society attended the lecture, which was opened by CeMM’s Scientific Director Prof. Giulio Superti-Furga, who acknowledged…
#Vienna #Lecture 
Lange Nacht der Forschung (Long Night of Science) 2014
Lange Nacht der Forschung (Long Night of Science) 2014 (Vienna, 4 April 2014) Counting more than 135.000 visitors of all ages the ‘Lange Nacht der Forschung’ (Long Night of Science) 2014, a joint initiative of the Federal Ministry of Science, Research and Economy (BMWFW) and the Federal Ministry for Transport, Innovation and Technology (BMVIT), took place on Friday 4th April, at several locations throughout Austria. CeMM´s booth at the Aula der…
#Vienna #Lecture 
Entirely novel strategy to molecular anticancer therapy tricks malignant cells
New drug prevents tumour growth by inhibiting the nucleotide sanitizing enzyme MTH1 (Vienna, 2 April 2014) A ground-breaking study spearheaded by Scientific Director Giulio Superti-Furga at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences shows that fast-growing cancer cells are sensitive towards imbalances in the metabolism of nucleotides, the building blocks of DNA. This vulnerability can be exploited for a…
#Vienna #Lecture Herbert Gottweis
Herbert Gottweis, Professor at the University of Vienna and former Vice President of the Austrian Science Fund died prematurely on Monday, March 31, at the age of 56. We express our deepest condolences to his family and colleagues. We thank Herbert Gottweis for his professional and collegial support, and the great conversations we were privileged to hold on policy studies, the understanding of biomedical and healthcare transformation, and…
#Vienna #Lecture 
Empathy and Evidence – The Scientific Foundations of Palliative Medicine
Prof. Gian Domenico Borasio, M.D, Centre Hospitalier Universitaire Vaudois and University of Lausanne, gave the 3rd SMART lecture, on March 28th, 2014 at CeMM. Numerous scientists, clinicians and interested lay people witnessed a fascinating and thought-provoking lecture on “Empathy and Evidence – The Scientific Foundations of Palliative Medicine” followed by a lively forum discussion. Dr. Borasio, who is a leader in the science and…
#Vienna #Lecture Austria needs Science and Science needs Public Funding
Austrian research and universities need to be put on a solid financial basis!Please sign and invite your colleagues to join: http://www.wissenschaft-ist-zukunft.at/
#Vienna #Lecture 